T CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for T CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at tough T-Cell cancers
Disease control OngoingThis early-phase trial tests a new cell therapy for people with hard-to-treat T-cell leukemia or lymphoma. Researchers take a patient's own immune T-cells, modify them in the lab to recognize and attack cancer cells carrying the CD7 protein, and infuse them back. The main goals a…
Matched conditions: T CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
Cancer drug trial pulled before it even started
Disease control TerminatedThis was a planned early-stage study to test the safety of a new drug called MT-0169 in people with certain types of acute leukemia that had come back or not responded to treatment. The study was withdrawn before any participants were enrolled, so no results are available.
Matched conditions: T CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC